CD63 and cancer: We also previously showed that inhibition of exosome release from cancer cells using GW4869 decreased transfer of CD63 mAb conjugated with anti-miR oligonucleotide complexes into Cal27 human oral squamous carcinoma cells and that the oligonucleotide complexes incorporated into cells by adding exosomes under a serum-free culture condition [20].